Lumentum: Sold Out Is Not The Same As Scalable

Lumentum reports record demand tied to AI-era compute scaling, supported by a strong moat in 200G EMLs and high-power lasers. Management is targeting $40 in adjusted EPS for FY2028, but growth is constrained by indium phosphide fab capacity and the target is heavily reliant on OCS expansion, which carries competitive risk due to weaker defensibility than Lumentum’s core laser products.

Analysis

LITE has two distinct exposures: differentiated InP-based lasers, where constrained supply may support pricing and customer stickiness, and OCS, where value depends on adoption and defensibility that are less established. The key near-term question is not demand but how quickly qualified InP capacity becomes saleable output; expansion delays or yield issues would defer revenue while potentially increasing capital needs. Over 1–3 months, watch shipment growth against capacity additions, customer qualification, and any change in OCS deployment evidence. Over 6–18 months, OCS could broaden LITE’s addressable market, but successful adoption may also attract competing optical-network vendors and pressure returns before it contributes meaningfully to earnings. Treat the FY2028 adjusted-EPS objective as an execution scenario, not a valuation anchor: its sensitivity to OCS and capacity assumptions needs verification. The contrarian risk is that AI demand is real but investors capitalize constrained demand as if it were unconstrained earnings growth. No valuation, utilization, or customer-concentration data are provided, so the case does not support an unconditional entry or price target.

Key Decisions for Investors

• Avoid chasing a demand-led rally without evidence that InP capacity is converting into shipments. Consider a staged LITE position only after reported output and customer qualification confirm the supply ramp; cap exposure until then.
• Treat OCS as upside optionality, not the base-case earnings engine. Before adding on the FY2028 EPS narrative, verify independent evidence of deployments, repeat orders, and customer adoption beyond management targets.
• Set a thesis review trigger if capacity additions slip, shipment growth fails to follow demand, or guidance weakens. Those outcomes would shift the story from temporary bottleneck to execution risk.
• Monitor AI infrastructure spending and optical-network architecture choices over the next 6–18 months. Broader customer capex retrenchment or substitution toward competing approaches would challenge both the demand and OCS upside cases; absent valuation and positioning data, no options trade is warranted.